annual CFI:
-$47.50M-$321.54M(-117.33%)Summary
- As of today (June 22, 2025), BPMC annual cash flow from investing activities is -$47.50 million, with the most recent change of -$321.54 million (-117.33%) on December 31, 2024.
- During the last 3 years, BPMC annual CFI has risen by +$178.36 million (+78.97%).
- BPMC annual CFI is now -117.33% below its all-time high of $274.04 million, reached on December 31, 2023.
Performance
BPMC Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$65.08M+$31.37M(+93.06%)Summary
- As of today (June 22, 2025), BPMC quarterly cash flow from investing activities is $65.08 million, with the most recent change of +$31.37 million (+93.06%) on March 31, 2025.
- Over the past year, BPMC quarterly CFI has dropped by -$12.05 million (-15.63%).
- BPMC quarterly CFI is now -62.34% below its all-time high of $172.79 million, reached on March 31, 2023.
Performance
BPMC quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$59.55M-$12.05M(-25.37%)Summary
- As of today (June 22, 2025), BPMC TTM cash flow from investing activities is -$59.55 million, with the most recent change of -$12.05 million (-25.37%) on March 31, 2025.
- Over the past year, BPMC TTM CFI has dropped by -$237.93 million (-133.39%).
- BPMC TTM CFI is now -121.73% below its all-time high of $274.04 million, reached on December 31, 2023.
Performance
BPMC TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BPMC Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -117.3% | -15.6% | -133.4% |
| 3 y3 years | +79.0% | +258.4% | +85.1% |
| 5 y5 years | -188.5% | +8.7% | -29.7% |
BPMC Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -117.3% | +79.0% | -62.3% | +134.6% | -121.7% | +86.6% |
| 5 y | 5-year | -117.3% | +89.1% | -62.3% | +115.1% | -121.7% | +87.8% |
| alltime | all time | -117.3% | +89.1% | -62.3% | +115.1% | -121.7% | +87.8% |
BPMC Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $65.08M(+93.1%) | -$59.55M(+25.4%) |
| Dec 2024 | -$47.50M(-117.3%) | $33.71M(+12.5%) | -$47.50M(+1846.0%) |
| Sep 2024 | - | $29.95M(-115.9%) | -$2.44M(-94.2%) |
| Jun 2024 | - | -$188.29M(-344.1%) | -$41.98M(-123.5%) |
| Mar 2024 | - | $77.13M(-2.1%) | $178.38M(-34.9%) |
| Dec 2023 | $274.04M(-283.3%) | $78.77M(-921.7%) | $274.04M(+93.0%) |
| Sep 2023 | - | -$9.59M(-129.9%) | $141.99M(+634.2%) |
| Jun 2023 | - | $32.07M(-81.4%) | $19.34M(-69.9%) |
| Mar 2023 | - | $172.79M(-424.3%) | $64.34M(-143.0%) |
| Dec 2022 | -$149.54M(-33.8%) | -$53.28M(-59.7%) | -$149.54M(-66.3%) |
| Sep 2022 | - | -$132.24M(-271.6%) | -$443.21M(+114.2%) |
| Jun 2022 | - | $77.07M(-287.6%) | -$206.90M(-48.2%) |
| Mar 2022 | - | -$41.09M(-88.2%) | -$399.15M(+76.7%) |
| Dec 2021 | -$225.86M(-48.0%) | -$346.95M(-433.4%) | -$225.86M(-595.7%) |
| Sep 2021 | - | $104.07M(-190.4%) | $45.56M(-109.3%) |
| Jun 2021 | - | -$115.18M(-187.1%) | -$488.65M(+35.0%) |
| Mar 2021 | - | $132.20M(-275.0%) | -$361.91M(-16.7%) |
| Dec 2020 | -$434.25M(+2537.2%) | -$75.53M(-82.4%) | -$434.25M(+49.2%) |
| Sep 2020 | - | -$430.14M(-3820.6%) | -$290.98M(-236.2%) |
| Jun 2020 | - | $11.56M(-80.7%) | $213.69M(-565.4%) |
| Mar 2020 | - | $59.86M(-11.6%) | -$45.92M(+178.9%) |
| Dec 2019 | -$16.47M | $67.74M(-9.1%) | -$16.47M(-41.1%) |
| Sep 2019 | - | $74.54M(-130.0%) | -$27.96M(-67.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$248.05M(-377.7%) | -$85.91M(-158.3%) |
| Mar 2019 | - | $89.31M(+58.8%) | $147.35M(-191.5%) |
| Dec 2018 | -$161.09M(+122.7%) | $56.24M(+239.0%) | -$161.09M(-3.8%) |
| Sep 2018 | - | $16.59M(-212.2%) | -$167.46M(-12.7%) |
| Jun 2018 | - | -$14.79M(-93.3%) | -$191.92M(-41.4%) |
| Mar 2018 | - | -$219.13M(-539.4%) | -$327.26M(+352.4%) |
| Dec 2017 | -$72.35M(-66.9%) | $49.87M(-733.6%) | -$72.35M(-72.2%) |
| Sep 2017 | - | -$7.87M(-94.8%) | -$260.51M(-2.9%) |
| Jun 2017 | - | -$150.14M(-519.5%) | -$268.25M(+138.1%) |
| Mar 2017 | - | $35.79M(-125.9%) | -$112.67M(-48.5%) |
| Dec 2016 | -$218.82M(+3499.6%) | -$138.29M(+785.4%) | -$218.82M(+159.8%) |
| Sep 2016 | - | -$15.62M(-386.7%) | -$84.22M(+21.3%) |
| Jun 2016 | - | $5.45M(-107.7%) | -$69.42M(-7.6%) |
| Mar 2016 | - | -$70.36M(+1810.0%) | -$75.16M(+1136.4%) |
| Dec 2015 | -$6.08M(+768.4%) | -$3.68M(+348.2%) | -$6.08M(+117.6%) |
| Sep 2015 | - | -$822.00K(+185.4%) | -$2.79M(+29.3%) |
| Jun 2015 | - | -$288.00K(-77.6%) | -$2.16M(+14.3%) |
| Mar 2015 | - | -$1.28M(+222.1%) | -$1.89M(+170.1%) |
| Dec 2014 | -$700.00K(+172.4%) | -$399.00K(+111.1%) | -$700.00K(+132.6%) |
| Sep 2014 | - | -$189.00K(+950.0%) | -$301.00K(+168.8%) |
| Jun 2014 | - | -$18.00K(-80.9%) | -$112.00K(+19.1%) |
| Mar 2014 | - | -$94.00K | -$94.00K |
| Dec 2013 | -$257.00K | - | - |
FAQ
- What is Blueprint Medicines annual cash flow from investing activities?
- What is the all time high annual CFI for Blueprint Medicines?
- What is Blueprint Medicines annual CFI year-on-year change?
- What is Blueprint Medicines quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Blueprint Medicines?
- What is Blueprint Medicines quarterly CFI year-on-year change?
- What is Blueprint Medicines TTM cash flow from investing activities?
- What is the all time high TTM CFI for Blueprint Medicines?
- What is Blueprint Medicines TTM CFI year-on-year change?
What is Blueprint Medicines annual cash flow from investing activities?
The current annual CFI of BPMC is -$47.50M
What is the all time high annual CFI for Blueprint Medicines?
Blueprint Medicines all-time high annual cash flow from investing activities is $274.04M
What is Blueprint Medicines annual CFI year-on-year change?
Over the past year, BPMC annual cash flow from investing activities has changed by -$321.54M (-117.33%)
What is Blueprint Medicines quarterly cash flow from investing activities?
The current quarterly CFI of BPMC is $65.08M
What is the all time high quarterly CFI for Blueprint Medicines?
Blueprint Medicines all-time high quarterly cash flow from investing activities is $172.79M
What is Blueprint Medicines quarterly CFI year-on-year change?
Over the past year, BPMC quarterly cash flow from investing activities has changed by -$12.05M (-15.63%)
What is Blueprint Medicines TTM cash flow from investing activities?
The current TTM CFI of BPMC is -$59.55M
What is the all time high TTM CFI for Blueprint Medicines?
Blueprint Medicines all-time high TTM cash flow from investing activities is $274.04M
What is Blueprint Medicines TTM CFI year-on-year change?
Over the past year, BPMC TTM cash flow from investing activities has changed by -$237.93M (-133.39%)